Invests in
Sectors:
Locations:
Min Investment:
$5,000,000.00Max Investment:
$35,000,000.00Target Investment:
$20,000,000.00
Skills
Lists including Olivier
Investments
SciRhom
Total Funding: $68M
MMI
Total Funding: $210M
Ariceum Therapeutics
Total Funding: $52M
JenaValve Technology
Total Funding: $270M
Mineralys Therapeutics
Total Funding: $240M
TargED Biopharmaceuticals
Total Funding: $44M
T-knife
Total Funding: $200M
Medlumics
Total Funding: $64M
Arvelle Therapeutics
Total Funding: $220M
Realeve
Total Funding: $110M
Endosense
Total Funding: $120M
Vivoryon Therapeutics
Total Funding: $73M
SuperSonic Imagine
Total Funding: $71M
TME Pharma
Total Funding: $91M
Work Experience
2018
Partner
2018
ANDERA PARTNERS (formerly EdRIP, Edmond de Rothschild Investment Partners) is a leading European Private Equity House, managing more than €2 bn in Life Sciences Venture Capital, Growth Capital, LBO, and Sponsorless Mezzanine Olivier is a partner in Andera Partners' life sciences franchise constituted by its BioDiscovery funds. The team manages around Euro 700 m of assets. The latest fund BioDiscovery 5 was closed in January 2018 at Euro 345 m. As its predecessors, it targets investments in biotech and medtech companies in Europe and the US.
2006 - 2018
Partner
2006 - 2018
Partner in the Life Science fund franchise BioDiscovery. 380 m€ under management via funds BioDiscovery I, II, III and IV. Paris based and investing in Europe and US.
2000 - 2006
Director
2000 - 2006
- member of the 3i healthcare practice - focussing purely on investments into biotechnology, biopharma, medtech, healthcare companies - responsible for the French market but involved in European and US wide investments and investment projects - member of boards in investee companies
1998 - 2001
Associate
1998 - 2001
1994 - 1998
Research Scientist
1994 - 1998
Department of Molecular Microbiology